Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function
Abstract Background Although reticulocalbin 3 (Rcn3) has a critical role in alveolar epithelial function as well as in pathogenesis of pulmonary fibrosis, no study has yet examined its diagnostic and prognostic values for interstitial lung disease (ILD). This study aimed to evaluate Rcn3 as a potent...
Main Authors: | Fangping Ding, Liu Yang, Yingfei Wang, Jing Wang, Yingmin Ma, Jiawei Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-023-02360-4 |
Similar Items
-
Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function
by: Fangping Ding, et al.
Published: (2024-06-01) -
Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
by: Mengshu Cao, et al.
Published: (2019-11-01) -
Osteopontin as a Biomarker in Interstitial Lung Diseases
by: David Iturbe-Fernández, et al.
Published: (2024-05-01) -
TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation
by: Mingting Wu, et al.
Published: (2023-09-01) -
Clinical-Epidemiological Profile and Distribution of Interstitial Lung Diseases: A Tertiary Care Centre Experience from North India
by: Anubhuti Singh, et al.
Published: (2024-09-01)